And the label pushes in the opposite direction on the acute end: warning 5.5 concerns acute kidney injury due to volume depletion , with postmarketing reports in patients who became dehydrated from nausea, vomiting or diarrhea
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Ong T.P., Cardozo M.T., de Conti A., Moreno F.S
Caution: Compounded semaglutide is not FDA-approved and should only be used under the supervision of a licensed provider
We were interested in finding which drug gives the most weight loss and doesnt have higher rates of side effects like nausea and gastrointestinal problems
Your plan may change based on your response, the underlying diagnosis, and whether youre combining IGF with other treatments
Clinical evidence from large-scale trials, including SUSTAIN-6, demonstrates that Ozempic does not increase cardiovascular risk and may offer protective benefits for certain high-risk patients